Year: 2025
Type: article
Abstract: Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Older Adults (DAN-RSV; NCT06684743).The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate.For more information, visit the Author Center.
Authors: Kristoffer Grundtvig Skaarup, Mats C. Højbjerg Lassen, Niklas Dyrby Johansen, Sine H. Christensen, Negar Aliabadi, Daniel Modin, Brian L. Claggett, Carsten S. Larsen, Lykke Larsen, Lothar Wiese, Michael Dalager-Pedersen, Matias G. Lindholm, Anne Marie R. Jensen, Maria Dons, Katrine F. Bernholm, Filip S. Davidovski, Lisa S. Duus, Camilla I. Ottosen, Anne B. Nielsen, Julie H. Borchsenius, Caroline Espersen, Güldas Köse, Frederik H. Fussing, Lars Køber, Scott D. Solomon, Jens Ulrik Stæhr Jensen, Cyril Jean-Marie Martel, Alexandre Mebazaa, Bradford D. Gessner, Claudia Schwarz, Elisa Gonzalez, Mette Skovdal, Pingping Zhang, Elizabeth Begier, Tor Biering-Sørensen
Institutions: University of Copenhagen, Copenhagen University Hospital, Gentofte Hospital, Pfizer (United States), Brigham and Women's Hospital, Harvard University, Aarhus University Hospital, Odense University Hospital, Roskilde Sygehus, Zealand University Hospital, Aalborg University Hospital, Rigshospitalet, Statens Serum Institut, Inserm, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, Hôpital Saint-Louis, Marqueurs cardiovasculaires en situation de stress, Steno Diabetes Center Copenhagen
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $7,166
Funder: Pfizer
OpenAlex ID: W4413860699